The Companies and Allied Matters Act 2020 (CAMA 2020) transforms Nigeria’s insolvency landscape by replacing the liquidation-heavy model with business rescue mechanisms such as administration and Company Voluntary Arrangements (CVA)—drawing on the UK’s Insolvency Act.

By empowering qualified insolvency practitioners to intervene early, the law aims to protect viable companies, preserve jobs and improve outcomes for creditors. While the statutory moratorium and rescue focus are major advances, the absence of cross-border insolvency provisions and weak enforcement of practitioner standards remain key challenges.

Open banking is set to officially launch in Nigeria by August 2025, marking a new era for data driven financial services. With the Central Bank’s framework in place, the system promises innovation and inclusion but also raises questions around privacy, security, and compliance.

This article delves into the role of compulsory licensing as a legal mechanism for facilitating access to patented pharmaceuticals in the context of public health emergencies. While patents are essential in fostering pharmaceutical innovation, they often impose barriers to access in low-income regions. International legal frameworks, particularly the TRIPS Agreement and the Doha Declaration, empower nations to issue compulsory licenses, enabling the appropriation of patented technologies without the holder’s consent to prioritise public health needs.

This discussion highlights the critical necessity for robust legal structures that balance the protection of intellectual property rights with the imperative to ensure that life-saving therapies are accessible during health crises.